-
1341
Evaluation of S100A8/A9 and neutrophils as prognostic markers in metastatic melanoma patients under immune-checkpoint inhibition
Published 2025-02-01“…Measuring S100A8/A9 and neutrophils could enhance immunotherapy monitoring by predicting impaired clinical outcomes and non-response to ICIs. …”
Get full text
Article -
1342
Prognostic factors and outcomes of adjuvant and first-line metastatic treatments in melanoma a Turkish oncology group study
Published 2025-01-01“…In our study, dabrafenib plus trametinib combination was more effective in adjuvant treatment of melanoma, while immunotherapy was more effective in metastatic first-line treatment.…”
Get full text
Article -
1343
AI-based tumor-infiltrating lymphocyte scoring system for assessing HCC prognosis in patients undergoing liver resection
Published 2025-02-01“…The scoring system combined with artificial intelligence is essential for automated, quantitative, whole-slide image-level assessment of TILs, which can be widely applied to quantify the immune profile of multi-cancer disease types with the discussion of subsequent immunotherapy.…”
Get full text
Article -
1344
Dicoumarol sensitizes hepatocellular carcinoma cells to ferroptosis induced by imidazole ketone erastin
Published 2025-02-01“…It not only inhibits tumor growth but also enhances immunotherapy responses and overcomes drug resistance in cancer therapy. …”
Get full text
Article -
1345
New Immunotherapeutic Approaches for Glioblastoma
Published 2021-01-01“…In this review, we summarize and discuss promising immunotherapies for GBM currently under preclinical investigation as well as in clinical trials.…”
Get full text
Article -
1346
Complete Recovery from COVID-19 Bilateral Pneumonia in an Immunosuppressed Man with Immune-Mediated Necrotizing Myopathy
Published 2020-01-01“…Immune-mediated necrotizing myopathy (IMNM) is a rare form of idiopathic immune myopathy (IIM) that requires immunotherapies, including immunosuppressive medications, if severe. …”
Get full text
Article -
1347
The Impact of the Myeloid Response to Radiation Therapy
Published 2013-01-01“…Radiation therapy is showing potential as a partner for immunotherapies in preclinical cancer models and early clinical studies. …”
Get full text
Article -
1348
Nontuberculous mycobacterial infections following teclistamab in multiple myeloma
Published 2025-02-01Get full text
Article -
1349
Chemotherapy for Metastatic Gastric Cancer
Published 2025-01-01“…This review evaluates landmark studies on chemotherapy for unresectable or metastatic gastric cancer, including targeted therapies and immunotherapies.…”
Get full text
Article -
1350
Targeting ferroptosis: a promising approach for treating lung carcinoma
Published 2025-01-01“…The efficacy of targeted therapies and immunotherapies is commonly compromised by the emergence of drug resistance and other factors, resulting in a lack of durable therapeutic benefits. …”
Get full text
Article -
1351
-
1352
Exosome-Associated Gene Signature for Predicting the Prognosis of Ovarian Cancer Patients
Published 2023-01-01“…Afterwards, the low-risk group had higher IPS across the four immunotherapies, implying that it had better effects of immunotherapies. …”
Get full text
Article -
1353
From Global Insights to National Impact: Advancing Cardio-Oncology in Iraq
Published 2024-12-01“…Advances in cancer therapies—including immunotherapies (e.g., checkpoint inhibitors, gene-targeted therapies), antibody-based cancer toxins, chemotherapy, radiotherapy, and surgery—have significantly improved survival rates 1,2. …”
Get full text
Article -
1354
Insights into the Roles of B Cells in Patients with Sepsis
Published 2023-01-01“…Finally, potential B-cell-related immunotherapies for sepsis are explored.…”
Get full text
Article -
1355
Sequential Release HydroLipo System for STING Gene Epigenetic Reprogramming and Immune Activation in Glioblastoma
Published 2025-02-01“…Inhibition of the intrinsic STING pathway in GBM hampers the effectiveness of immunotherapies. To overcome this clinical limitation, a Sequential Release HydroLipo System (SRHLS) is developed, in which hydrogels and nanoparticles are combined for controlled drug release. …”
Get full text
Article -
1356
Single-Domain Antibody-Based TCR-Like CAR-T: A Potential Cancer Therapy
Published 2020-01-01“…This review provides the probable optimized initiatives for improving TCR-like CAR-T reprogramming and discusses single-domain antibodies administered as an alternative to conventional scFvs and secreted by CAR-T cells, which might be of great value to the development of CAR-T immunotherapies for intracellular antigens.…”
Get full text
Article -
1357
Differential Regulation of NK Cell Receptors in Acute Lymphoblastic Leukemia
Published 2022-01-01“…Cancer immunotherapies are preferred over conventional treatments which are highly cytotoxic to normal cells. …”
Get full text
Article -
1358
Treatment of Bleeding Diathesis Associated with a Heparin-Like Anticoagulant in Plasma Cell Neoplasia Using Protamine
Published 2018-01-01“…We postulate that chemotherapy, targeted therapies, and immunotherapies may also disrupt production of a HLAC. …”
Get full text
Article -
1359
Automatic Generation of Validated Specific Epitope Sets
Published 2015-01-01“…Accurate measurement of B and T cell responses is a valuable tool to study autoimmunity, allergies, immunity to pathogens, and host-pathogen interactions and assist in the design and evaluation of T cell vaccines and immunotherapies. In this context, it is desirable to elucidate a method to select validated reference sets of epitopes to allow detection of T and B cells. …”
Get full text
Article -
1360
Colorectal Polyposis and Immune-Based Therapies
Published 2004-01-01“…Currently, adjuvant immunotherapies such as recombinant gene therapy and antibody-cytokine fusion proteins are assuming a more significant role in the management of colorectal neoplasia. …”
Get full text
Article